Ribbon Acquisition Corp.

Ribbon Acquisition Corp. received a staff determination letter from Nasdaq on June 4, 2026, notifying the company of Nasdaq's decision to delist its securities. This action stems from the company's failure to pay $75,000 in required Nasdaq listing fees. Ribbon Acquisition Corp. plans to appeal the determination to a Hearings Panel, which will temporarily stay the delisting process. The company is in discussions with Nasdaq to resolve the outstanding fees but cannot guarantee the maintenance of its Nasdaq listing.

Ribbon Acquisition Corp. (RIBB) announced a definitive Business Combination Agreement with DRC Medicine Inc., a company focused on AI-powered allergy and infection diagnostic kits, valuing the target at $350 million. Shareholders also approved an extension of the business combination period to January 16, 2027, which led to the redemption of 1,436,867 public shares for $14.94 million. For the first quarter of 2026, the company reported a net income of $252,755, an increase from the prior year, but also noted a working capital deficit of $1.01 million and a significant decrease in cash held in the trust account.

Ribbon Acquisition Corporation (RIBB) filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The filing confirms the company's status as a non-accelerated filer, smaller reporting company, and emerging growth company. It also indicates that the registrant has filed all required reports and interactive data files during the preceding 12 months.

Ribbon Acquisition Corp. (RIBB) announced a deposit of $125,000 into its trust account on April 14, 2026. This deposit secures a one-month extension for the company to complete its initial business combination. The extension is in accordance with the Extension Amendment and Trust Amendment previously approved by shareholders, which allow for monthly extensions upon the deposit of funds into the trust account for the benefit of public shareholders.

Ribbon Acquisition Corp. announced the adjournment of its Extraordinary General Meeting of Shareholders, originally scheduled for April 13, 2026. The meeting has been rescheduled to Monday, September 14, 2026, at 10:00 a.m. Eastern Time. This adjournment aims to provide the company with additional time to solicit proxies for the proposals outlined in the meeting notice and proxy statement. Shareholders of record as of February 18, 2026, remain eligible to vote, and previously submitted proxies will be honored.

Ribbon Acquisition Corp. announced the adjournment of its Extraordinary General Meeting of Shareholders, originally scheduled for April 13, 2026. The meeting has been rescheduled to Monday, September 14, 2026, at 10:00 a.m. Eastern Time. This adjournment aims to provide the company with additional time to solicit proxies for the proposals outlined in the meeting notice and proxy statement. Shareholders of record as of February 18, 2026, remain eligible to vote.